Search results
Showing 7381 to 7395 of 8213 results
Interventional procedures, IPG103 - Issued: December 2004 --> This guidance has been updated and replaced by NICE interventional procedure guidance 489.
Radiofrequency ablation of the soft palate for snoring (IPG124)
Interventional procedures, IPG124 - Issued: May 2005 --> This guidance has been replaced by NICE interventional procedure guidance 476.
Single mini-incision surgery for total hip replacement (IPG152)
Summary --> This guidance has been updated and replaced by NICE interventional procedure guidance 363.
Percutaneous fetal balloon valvuloplasty for aortic stenosis (IPG175)
Interventional procedures, IPG175 - Issued: May 2006 --> This guidance has been updated and replaced by NICE interventional procedures guidance 613.
Interventional procedures, IPG194 - Issued: November 2006 --> This guidance has been updated and replaced by NICE interventional procedure guidance 535.
Interventional procedures, IPG228 - Issued: August 2007 --> This guidance has been updated and replaced by NICE interventional procedures guidance 639.
Interventional procedures, IPG235 - Issued: October 2007 --> This guidance has been updated and replaced by NICE interventional procedures guidance 628.
Transcranial magnetic stimulation for severe depression (IPG242)
Interventional procedures, IPG242 - Issued: November 2007 --> This guidance has been updated and replaced by NICE interventional procedure guidance 542.
Interventional procedures, IPG260 - Issued: May 2008 --> This guidance has been updated and replaced by NICE interventional procedures guidance 591.
Systemic juvenile idiopathic arthritis: canakinumab (ESNM36)
This evidence summary has been withdrawn. An NHS England clinical commissioning policy statement on biologic therapies for the treatment of juvenile idiopathic arthritis is available.
Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system (ESNM41)
This evidence summary has been replaced by the long-acting reversible contraception: implementation resource summary.
Critical limb ischaemia in peripheral vascular disease: intravenous iloprost (ESUOM24)
April 2019: This evidence summary has been withdrawn because a product containing intravenous iloprost with a marketing authorisation for treating critical limb ischaemia in peripheral vascular disease is now available in the UK.
November 2024: This evidence summary has been withdrawn because licensed products are now available.
Autologous haematopoietic stem cell transplantation for treating multiple sclerosis [ID1111]
Discontinued Reference number: GID-TA10306
Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID968]
Discontinued Reference number: GID-TA10334